Investors

Financials & Filings

Document Details

Form
8-A12B
Filing Date
Oct 10, 2014
Document Date
Oct 10, 2014
Form Description
Registration of certain classes of securities 12(b) of the Securities Exchange Act
Filing Group
Registration Statements
Company
Xenon Pharmaceuticals Inc.
Issuer
Xenon Pharmaceuticals Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Investor inquiries

Tucker Kelly 
Chief Financial Officer
investors@xenon-pharma.com
 

Request Information

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals

Sign Up